Bank of America analysts Brad Sills and Madeline Brooks updated their opinion on Oracle stock after attending Oracle’s ...

From plans to embed OpenAI technology into its patient portal to expanding its collaboration with Ascension, here’s a look at how EHR giant Oracle Health is growing and forging new partnerships in ...

Despite Oracle's impressive performance, I believe Palantir (NASDAQ: PLTR) -- with a current value of $422 billion -- will be worth more than Oracle by 2030.

Or does it portend something alarming about the market?

Was it something they said? Oracle shares fell 7% on Friday, a day after the software and cloud firm offered investors ...

The takeaway may be no more complex than a decision by investors that the stock, which remains roughly 30% above its lowest ...

After yesterday's presentation, investors "sold the news" after a strong run in the stock over the past two months.

Oracle Corporation (NYSE: ORCL) sets aggressive long-term growth targets for its cloud and AI infrastructure, with strong ...

The company has laid out an aggressive new forecast, with a path to nearly quadrupling revenue by fiscal 2030 and a backlog ...

Oracle ORCL is gearing up for its next phase of growth, backed by an expanding contract pipeline and a surge in demand for ...

And then he will obviously be talking about OCI and Oracle Infrastructure; followed by Mike, who will take a discussion first initially on the application business and then Mike will then continue on ...

Oracle's heavy reliance on OpenAI poses valuation risks. Explore expert insights on market expectations and competition.